Saint Louis Encephalitis Virus
Saint Louis encephalitis virus (SLEV) is a New World positive-sense RNA arbovirus in the genus Orthoflavivirus (family Flaviviridae) whose South American phylogenetic lineages (Genotypes III, V, VII, and VIII) circulate between Culex quinquefasciatus mosquitoes and columbiform doves such as Zenaida auriculata across Argentina, Brazil, Peru, and Uruguay.
Saint Louis encephalitis virus (SLEV; species Orthoflavivirus louisense, genus Orthoflavivirus, family Flaviviridae) is an enveloped, positive-sense, single-stranded RNA arbovirus distributed throughout the Western Hemisphere from southern Canada to central Patagonia in Argentina. Within the genus Orthoflavivirus, Saint Louis encephalitis virus belongs to the Japanese encephalitis antigenic complex alongside West Nile virus, Japanese encephalitis virus, Murray Valley encephalitis virus, and Usutu virus, and is closely allied to the Neotropical Ntaya-group viruses Ilheus virus and Rocio virus.
Although first isolated in North America during a summer encephalitis epidemic in St. Louis, Missouri, in 1933, coalescent phylogeographic reconstructions indicate that Saint Louis encephalitis virus originated in tropical South America and radiated into eight major genetic lineages (Genotypes I through VIII). In South America—where Genotypes III, V, VII, and VIII circulate across Argentina, Brazil, Peru, Uruguay, French Guiana, and Trinidad—the virus is maintained in urban, peri-urban, and agro-ecosystem cycles connecting ornithophilic Culex quinquefasciatus and sylvatic Culex (Melanoconion) mosquitoes with amplifying columbiform birds, particularly the eared dove (Zenaida auriculata).
Historical Discovery and Pan-American Phylogeography
The 1933 Missouri Recognition and Early South American Isolations
Saint Louis encephalitis virus was first isolated in late summer 1933 by Ralph S. Muckenfuss, Charles Armstrong, and H. A. McCordock (and independently by Leslie T. Webster and George L. Fite) from brain tissue of fatal encephalitis patients during an outbreak of over 1,000 cases in St. Louis County, Missouri. Field entomology by William McD. Hammon and William C. Reeves in Washington State during the early 1940s established the bird–Culex–bird transmission paradigm for encephalitic flaviviruses.
In South America, arboviral surveillance begun in the 1950s and 1960s by the Belém Virus Laboratory (Instituto Evandro Chagas) in Pará, Brazil, and the Instituto Nacional de Microbiología in Argentina recovered Saint Louis encephalitis virus strains from sylvatic mosquitoes (Culex declarator, Culex coronator, Psorophora ferox, Sabethes belisarioi), sentinel monkeys, wild birds, and rodents across Neotropical forests and temperate grasslands.
Eight Phylogenetic Genotypes and South American Lineages
Molecular phylogenetic analyses of the Envelope (E) and NS5 genes classify Saint Louis encephalitis virus into eight genotypes (Genotypes I–VIII), with the deepest basal branches rooted in South America:
| Genotype | Geographic Distribution | Ecological & Epidemiological Associations |
|---|---|---|
| Genotypes I & II | North America & Caribbean/Brazil | Maintained by Culex pipiens, Cx. quinquefasciatus, Cx. tarsalis, and Cx. nigripalpus; North American epidemics |
| Genotype III | Southern Cone (Argentina, Brazil) | Isolated from Culex quinquefasciatus; caused the 2005 Córdoba, Argentina neuroinvasive outbreak |
| Genotypes IV & VI | Panama & Colombia | Sylvatic and peri-rural circulation in Culex and Mansonia mosquitoes |
| Genotype V (VA & VB) | Pan-Amazonian Basin & Argentina | Distributed across Amazonian forests (Brazil, Peru, French Guiana, Trinidad) and Argentine wetlands |
| Genotype VII | Argentina (Corrientes, Córdoba, Chaco) | Isolated from wild rodents (Calomys musculinus, Mus musculus) and Culex mosquitoes |
| Genotype VIII | Amazonian Brazil (Pará) & Peru | Basal Amazonian rainforest lineage recovered from canopy birds and forest Culex species |
Virion Architecture and Genome Organization
The mature Saint Louis encephalitis virion is an icosahedral enveloped particle ~50 nanometers in diameter, coated by 90 homodimers of the Envelope (E) glycoprotein (~53 kDa) and M protein (~8 kDa). The positive-sense single-stranded RNA genome measures 10,936 to 10,940 nucleotides, bearing a 5' Type 1 methylated cap (m7GpppAm2'-O) and lacking a 3' poly(A) tail. A single open reading frame (~3,430 codons) encodes the viral polyprotein (C–prM–E–NS1–NS2A–NS2B–NS3–NS4A–2K–NS4B–NS5). Conserved pseudoknots in the 3' UTR stall host XRN1 exoribonuclease to generate subgenomic flaviviral RNA (sfRNA), which modulates replication in Culex midgut cells and antagonizes vertebrate type I interferon signaling alongside NS5.
South American Transmission Ecology: Culex Vectors and Avian Hosts
Urban and Peri-Urban Vector Ecology: Culex quinquefasciatus
Across temperate and subtropical South America—including central and northern Argentina, Uruguay, and southern and southeastern Brazil—the primary urban and peri-urban vector of Saint Louis encephalitis virus is the southern house mosquito, Culex quinquefasciatus. Female Culex quinquefasciatus mosquitoes oviposit egg rafts in organically enriched peridomestic water collections (drainage ditches, septic tanks, retention ponds, and irrigated agro-industrial channels) and feed nocturnally inside and around human dwellings.
Experimental vector-competence studies and field isolations conducted in Córdoba and Santa Fe provinces by Luis Adrián Diaz, Marta S. Contigiani, Walter R. Almirón, and colleagues identified two additional competent vectors: Culex interfor and Culex saltanensis, which bridge transmission between peri-urban wetlands and residential neighborhoods. In the Amazon Basin, sylvatic circulation is driven by Culex (Melanoconion) species (Cx. pedroi, Cx. portesi, Cx. spissipes), Culex declarator, and Culex coronator.
Columbiform Amplifying Reservoirs: Zenaida auriculata
Whereas North American transmission relies heavily on passerine birds, ecological investigations across Argentina and southern Brazil established that columbiform doves—specifically the eared dove (Zenaida auriculata) and the picui ground dove (Columbina picui)—serve as the primary vertebrate amplifying hosts of Saint Louis encephalitis virus in South America.
Expansion of soybean, sorghum, and cereal agriculture across the Argentine Pampas, Espinal, and Chaco biomes has supported large communal roosts of Zenaida auriculata, which nest inside urban parks and boulevard trees. Experimental inoculations show that Zenaida auriculata develops high, sustained viremia titers (104.5 to 106.0 PFU/mL over 3 to 5 days) that exceed the oral infection threshold of blood-feeding Culex quinquefasciatus. Secondary avian hosts include the rufous hornero (Furnarius rufus), great kiskadee (Pitangus sulphuratus), and shiny cowbird (Molothrus bonariensis).
The 2005 Córdoba Outbreak, Clinical Neuropathogenesis, and Surveillance
Re-Emergence as an Urban Public Health Threat in Argentina and Brazil
Between January and May 2005, the city of Córdoba, Argentina, experienced the first major epidemic of Saint Louis encephalitis in South America, comprising 47 laboratory-confirmed human cases (predominantly acute meningoencephalitis in older adults) and 9 fatalities (~19 percent case-fatality among hospitalized neuroinvasive patients). Viral isolation from Culex quinquefasciatus mosquitoes collected during the outbreak proved that the epidemic was driven by the amplification of the neurovirulent Genotype III strain in urban Zenaida auriculata populations, displacing the less virulent endemic Genotype VII strain. Subsequent clusters were documented in Entre Ríos (2006), Buenos Aires Province (2010), and San Juan (2011).
In Brazil, molecular and serological surveillance conducted during large dengue fever epidemics in São José do Rio Preto and Ribeirão Preto (São Paulo State, 2006–2008) and Cuiabá (Mato Grosso State) detected acute human Saint Louis encephalitis virus infections (Genotypes III and V) presenting either as dengue-like febrile syndromes or viral meningoencephalitis, alongside widespread neutralizing antibodies in sentinel horses.
Clinical Presentation and Laboratory Diagnosis
In humans, more than 95 percent of Saint Louis encephalitis virus infections are asymptomatic or produce a self-limiting febrile headache. In symptomatic neuroinvasive cases—whose incidence rises in individuals over 55 years of age—an incubation period of 4 to 21 days is followed by abrupt fever, headache, nausea, and progression to febrile headache, aseptic meningitis, or acute encephalitis. Encephalitic involvement of the substantia nigra, basal ganglia, thalami, and cerebellar cortex manifests as confusion, neck rigidity, tremor of the eyelids, lips, and extremities, cranial nerve palsies, and syndrome of inappropriate antidiuretic hormone secretion (SIADH) after the virus crosses the blood-brain barrier.
Public health confirmation differentiates Saint Louis encephalitis virus from West Nile, dengue, Zika, Ilheus, and Rocio viruses using:
- Cerebrospinal Fluid and Serum RT-qPCR: Real-time reverse transcription PCR targeting the 5' UTR–capsid or NS5 regions during early viremia or acute neuroinvasion.
- Comparative PRNT90 Neutralization: Paired serum and cerebrospinal fluid testing by plaque reduction neutralization assay against a panel of co-circulating South American orthoflaviviruses.
Frequently Asked Questions
Why did Saint Louis encephalitis virus cause an urban epidemic in Córdoba, Argentina, in 2005 after decades of silent circulation?
Agricultural expansion and urban greening drove dense populations of the primary amplifying host, the eared dove (Zenaida auriculata), into urban neighborhoods alongside abundant Culex quinquefasciatus vectors, coinciding with the emergence of Genotype III, which produces higher and longer viremia in doves and higher neurovirulence in mammals than the previously circulating Genotype VII lineage.
How is Saint Louis encephalitis virus distinguished clinically and diagnostically from dengue in Brazil?
During seasonal arboviral outbreaks in Brazil, non-neuroinvasive Saint Louis encephalitis virus infections present with fever, headache, myalgia, retro-orbital pain, and occasional thrombocytopenia that resemble dengue fever. Definitive differentiation requires acute-phase multiplex RT-qPCR (days 1–5) or convalescent PRNT90 neutralization panels comparing Saint Louis encephalitis virus against all four dengue serotypes and Zika virus.
References
- Kramer, L. D., & Chandler, L. J. (2001). "Phylogenetic analysis of the envelope gene of St. Louis encephalitis virus." Archives of Virology, 146(12), 2341–2355. https://doi.org/10.1007/s007050170007
- Diaz, L. A., Ré, V., Almirón, W. R., et al. (2006). "Genotype III Saint Louis encephalitis virus outbreak, Argentina, 2005." Emerging Infectious Diseases, 12(11), 1752–1754. https://doi.org/10.3201/eid1211.060486
- Mondini, A., Cardeal, I. L. S., Lázaro, E., et al. (2007). "Saint Louis encephalitis virus, Brazil." Emerging Infectious Diseases, 13(1), 176–178. https://doi.org/10.3201/eid1301.060905
- Baillie, G. J., Kolokotronis, S.-O., Waltari, E., Maffei, J. G., Kramer, L. D., & Perkins, S. L. (2008). "Historical biogeography and molecular evolution of St. Louis encephalitis virus." Molecular Phylogenetics and Evolution, 47(2), 717–724. https://doi.org/10.1016/j.ympev.2008.02.015
- Diaz, A., Coffey, L. L., Burkett-Cadena, N., & Contigiani, M. S. (2018). "Reemergence of St. Louis encephalitis virus in the Americas." Emerging Infectious Diseases, 24(12), 2150–2157. https://doi.org/10.3201/eid2412.180372